Events - Pangea Biomed

February 5-7, 2025

Precision Medicine World Conference 2025

Location: Santa Clara, California

Our CEO, Dr. Tuvik Beker, will be presenting a Showcase at PMWC 2025 discussing the exciting progress Pangea Biomed has been making in unlocking the promise and hope of precision oncology for patients that need it most. He will discuss how ENLIGHT is empowering oncologists to make more informed treatment decisions, leading to better patient outcomes, and how ENLIGHT is accelerating the development of targeted cancer therapies, bringing new hope to patients faster. He will also be talking about what lies ahead: recent validations of ENLIGHT-DP (our next-generation predictive biomarker based on histopathology slide images), our regulatory roadmap, and our recent commercial launch.

March 18-20, 2024

BIO-Europe Spring 2024

Location: Barcelona, Spain

Our COO, Emmanuel Elalouf, attended BIO-Europe Spring 2024 to connect with leading pharma executives.

November 1 - 5, 2023

Society for Immunotherapy of Cancer (SITC)

Location: San Diego, California

Pangea presented a poster on the predictiveness of ENLIGHT technology.

June 15, 2023

ARC Summit 2023

Location: Tel Aviv, Israel

CEO Tuvik Beker gave a presentation about ENLIGHT at the ARC summit in Tel Aviv, Israel.

June 6 - 7, 2023

BIO International Convention 2023

Location: Boston, Massachusetts

COO Emmanuel Elalouf attended the Bio International Convention in Boston to meet with industry leaders and executives.

June 4 - 5, 2023

American Society of Clinical Oncology 2023

Location: Chicago, Illinois

Our CTO Ranit Aharonov and COO Emmanuel Elalouf attended ASCO 2023. Ranit presented two posters: one on our ENLIGHT technology and the other on the ENLIGHT-DP framework.

May 16 - 18, 2023

Biomed Israel 2023

Location: Tel Aviv, Israel

Our CEO Tuvik Beker gave a presentation on ENLIGHT at Biomed Israel 2023.

April 14 - 19, 2023

American Association of Cancer Research 2023

Location: Orlando, Florida

Our CEO Tuvik Beker and Head of Research Gal Dinstag attended AACR to connect with leading oncology executives. Gal presented two posters on ENLIGHT and the ENLIGHT-DP framework.

March 28 - 30, 2023

EACR-OECI Molecular Pathology Approach to Cancer

Location: Bergamo, Italy

Our CEO Tuvik Beker presented a talk titled, "ENLIGHT: Predicting response to cancer therapy based on gene expression patterns from RNAseq or H&E slides."

March 27 - 28, 2023

The New World of RNA Diagnostics and Therapeutics at the Elena Cancer Center

Location: Rome, Italy

CTO Ranit Aharonov presented a presentation titled, “Prediction of Cancer Treatment Response from Histopathology Images Through Imputed Transcriptomics.”